Search

everythinglearnresearchcommunity

for

Search:↓

Tislelizumab can cause cutaneous lupus erythematosus.

The combination of encorafenib and binimetinib caused few skin issues.

Follicular mycosis fungoides can look like a B-cell lymphoma, making diagnosis difficult.

Reducing gefitinib dosage improved hair loss, but scarring remained.

Autologous skin cell transplantation speeds up healing and xenografts improve skin color in burn care.

Nilotinib can cause keratosis pilaris, a skin condition.

Flamena, a liposomal mix, helps skin heal better after a chemical burn.

A man developed an allergic skin reaction after using brimonidine for rosacea.

Sorafenib can cause a temporary skin condition that goes away after stopping the drug.

A woman's skin darkened after using dutasteride and pimecrolimus for hair loss, but improved when she stopped the medications and protected her skin from light.

Centipeda minima and brevilin A protect skin cells from damage and aging.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

Immune checkpoint inhibitors can cause scalp inflammation and hair follicle issues.

The newborn's skin blisters healed without scarring, leaving some light spots, and stopped forming after four months.

Reducing immunosuppression and using antiviral creams improved the woman's skin condition.

Mast cells might contribute to hair loss by causing skin thickening.

Oral mTOR inhibitors often cause skin and hair side effects but usually don't require stopping treatment.

Rituximab treatment led to complete hair regrowth and improved skin in a woman with pemphigus foliaceus.

Ionizing radiation causes irreversible skin damage, with single doses leading to acute injury and hair graying, and fractional doses causing more severe long-term tissue damage.

Early changes in skin gene expression can predict later bone mass loss after radiation exposure.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Patients with cutaneous lupus erythematosus have a higher risk of skin cancer and other cancers.

Increased pigmentation may protect skin from UVB, new targets for skin disease treatments were identified, sunscreen ingredients don't affect hormones, TNF-α inhibitors may help diabetic wounds, and certain treatments could prevent chemotherapy-induced hair loss.

Some patients receiving pegylated interferon alfa injections developed skin necrosis, requiring treatment adjustments or discontinuation.

Treatment with prednisolone and dapsone stopped new blisters and partially healed previous ones.

Skin issues from chronic graft-versus-host disease greatly affect daily life, needing teamwork between blood and skin doctors.

Minocycline reduces acne rash, pyridoxine lowers hand-foot syndrome risk, and scalp cooling lessens hair loss from cancer treatments.

Nilotinib can cause generalized keratosis pilaris.

Some children who had stem cell transplants developed permanent hair loss, especially when treated with a drug called busulphan.